Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 | Research

Progression of severity in coronavirus disease 2019 patients before treatment and a self-assessment scale to predict disease severity

Authors: Ye Yao, Jie Tian, Xia Meng, Haidong Kan, Lian Zhou, Weibing Wang

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Objectives

This study aims to further investigate the association of COVID-19 disease severity with numerous patient characteristics, and to develop a convenient severity prediction scale for use in self-assessment at home or in preliminary screening in community healthcare settings.

Setting and participants

Data from 45,450 patients infected with COVID-19 from January 1 to February 27, 2020 were extracted from the municipal Notifiable Disease Report System in Wuhan, China.

Primary and secondary outcome measures

We categorized COVID-19 disease severity, based on The Chinese Diagnosis and Treatment Protocol for COVID-19, as “nonsevere” (which grouped asymptomatic, mild, and ordinary disease) versus “severe” (grouping severe and critical illness).

Results

Twelve scale items—age, gender, illness duration, dyspnea, shortness of breath (clinical evidence of altered breathing), hypertension, pulmonary disease, diabetes, cardio/cerebrovascular disease, number of comorbidities, neutrophil percentage, and lymphocyte percentage—were identified and showed good predictive ability (area under the curve = 0·72). After excluding the community healthcare laboratory parameters, the remaining model (the final self-assessment scale) showed similar area under the curve (= 0·71).

Conclusions

Our COVID-19 severity self-assessment scale can be used by patients in the community to predict their risk of developing severe illness and the need for further medical assistance. The tool is also practical for use in preliminary screening in community healthcare settings.

Summary

Our study constructed a COVID-19 severity self-assessment scale that can be used by patients in the community to predict their risk of developing severe illness and the need for further medical assistance.
Appendix
Available only for authorised users
Literature
2.
go back to reference Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497–506.CrossRef Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497–506.CrossRef
3.
go back to reference Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;8:89. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;8:89.
5.
go back to reference Oh J, Lee JK, Schwarz D, et al. National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries. Health Syst Reform. 2020;6:e1753464.CrossRef Oh J, Lee JK, Schwarz D, et al. National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries. Health Syst Reform. 2020;6:e1753464.CrossRef
6.
go back to reference Medical SAO. COVID-19 pandemic: triage for intensive-care treatment under resource scarcity. Swiss Med Wkly. 2020;150:20229. Medical SAO. COVID-19 pandemic: triage for intensive-care treatment under resource scarcity. Swiss Med Wkly. 2020;150:20229.
7.
go back to reference Joebges S, Biller-Andorno N. Ethics guidelines on COVID-19 triage-an emerging international consensus. Crit Care. 2020;24:201.CrossRef Joebges S, Biller-Andorno N. Ethics guidelines on COVID-19 triage-an emerging international consensus. Crit Care. 2020;24:201.CrossRef
8.
go back to reference Phua J, Weng L, Ling L, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506–17.CrossRef Phua J, Weng L, Ling L, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506–17.CrossRef
9.
go back to reference Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:7. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:7.
10.
go back to reference Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.CrossRef Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.CrossRef
11.
go back to reference Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8.CrossRef Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8.CrossRef
12.
go back to reference Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33.CrossRef Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33.CrossRef
13.
go back to reference Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. 2020;78:6. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. 2020;78:6.
14.
go back to reference Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRef Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRef
15.
go back to reference Wu S, Du Z, Shen S, et al. Identification and validation of a novel clinical signature to predict the prognosis in confirmed COVID-19 patients. Clin Infect Dis. 2020;7:552. Wu S, Du Z, Shen S, et al. Identification and validation of a novel clinical signature to predict the prognosis in confirmed COVID-19 patients. Clin Infect Dis. 2020;7:552.
16.
go back to reference Kim L, Garg S, O’Halloran A, et al. Factors R for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET. Clin Infect Dis. 2019;2020(9):e45. Kim L, Garg S, O’Halloran A, et al. Factors R for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET. Clin Infect Dis. 2019;2020(9):e45.
17.
go back to reference Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369: m1328.CrossRef Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369: m1328.CrossRef
18.
go back to reference Samuel G. Urwin GK, Sara Graziadio. What prognostic clinical risk prediction scores for COVID-19 are currently available for use in the community setting? Samuel G. Urwin GK, Sara Graziadio. What prognostic clinical risk prediction scores for COVID-19 are currently available for use in the community setting?
20.
go back to reference Xu J, Long JS. Confidence Intervals for Predicted Outcomes in Regression Models for Categorical Outcomes. Stata Journal. 2005;5:537–59.CrossRef Xu J, Long JS. Confidence Intervals for Predicted Outcomes in Regression Models for Categorical Outcomes. Stata Journal. 2005;5:537–59.CrossRef
21.
go back to reference Li B, Li X, Wang Y, et al. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019. Emerg Microbes Infect. 2020;9:787–93.CrossRef Li B, Li X, Wang Y, et al. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019. Emerg Microbes Infect. 2020;9:787–93.CrossRef
22.
go back to reference Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.
23.
go back to reference Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan. China PLoS One. 2020;15: e0230548.CrossRef Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan. China PLoS One. 2020;15: e0230548.CrossRef
24.
go back to reference Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715–23.CrossRef Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715–23.CrossRef
25.
go back to reference Hong KH, Choi JP, Hong SH, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018;73:286–9.CrossRef Hong KH, Choi JP, Hong SH, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018;73:286–9.CrossRef
26.
go back to reference Zhou Y, Yang Z, Guo Y, et al. A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China. medRxiv 2020:2020.03.24.20042119. Zhou Y, Yang Z, Guo Y, et al. A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China. medRxiv 2020:2020.03.24.20042119.
27.
go back to reference Liu Y, Mao B, Liang S, et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020;55:90. Liu Y, Mao B, Liang S, et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020;55:90.
28.
go back to reference Liu D, Wang Y, Lan L, et al. Overall reduced lymphocyte subsets worsening disease severity and prognosis in COVID-19 severe cases with diabetes mellitus in Chengdu, China, 08 April 2020, PREPRINT (Version 1) 2020. Liu D, Wang Y, Lan L, et al. Overall reduced lymphocyte subsets worsening disease severity and prognosis in COVID-19 severe cases with diabetes mellitus in Chengdu, China, 08 April 2020, PREPRINT (Version 1) 2020.
29.
30.
go back to reference Liang W, Liang H, Ou L, et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020;34:73243. Liang W, Liang H, Ou L, et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020;34:73243.
31.
go back to reference Bai X, Fang C, Zhou Y, et al. Predicting COVID-19 malignant progression with AI techniques. medRxiv 2020:2020.03.20.20037325. Bai X, Fang C, Zhou Y, et al. Predicting COVID-19 malignant progression with AI techniques. medRxiv 2020:2020.03.20.20037325.
32.
go back to reference Gong J, Ou J, Qiu X, et al. A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19): A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong. China Clin Infect Dis. 2020;35:e15535. Gong J, Ou J, Qiu X, et al. A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19): A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong. China Clin Infect Dis. 2020;35:e15535.
33.
go back to reference Huang H, Cai S, Li Y, et al. Prognostic factors for COVID-19 pneumonia progression to severe symptom based on the earlier clinical features: a retrospective analysis. medRxiv 2020:2020.03.28.20045989. Huang H, Cai S, Li Y, et al. Prognostic factors for COVID-19 pneumonia progression to severe symptom based on the earlier clinical features: a retrospective analysis. medRxiv 2020:2020.03.28.20045989.
Metadata
Title
Progression of severity in coronavirus disease 2019 patients before treatment and a self-assessment scale to predict disease severity
Authors
Ye Yao
Jie Tian
Xia Meng
Haidong Kan
Lian Zhou
Weibing Wang
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07386-3

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.